Prenatal diethylstilbestrol (DES) exposure is associated with uterine leiomyoma development
- 30 January 2005
- journal article
- Published by Elsevier BV in Reproductive Toxicology
- Vol. 20 (1), 81-84
- https://doi.org/10.1016/j.reprotox.2005.01.002
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Characterization of Uterine Leiomyomas in CD-1 Mice Following Developmental Exposure to Diethylstilbestrol (DES)Toxicologic Pathology, 2002
- Hysterectomy rates in the United States 1990–1997Obstetrics & Gynecology, 2002
- Uterine fibroidsThe Lancet, 2001
- Cellular and molecular effects of developmental exposure to diethylstilbestrol: implications for other environmental estrogens.Environmental Health Perspectives, 1995
- Diethylstilbestrol Revisited: A Review of the Long-Term Health EffectsAnnals of Internal Medicine, 1995
- Clonal Determination of Uterine Leiomyomas by Analyzing Differential Inactivation of the X-Chromosome-Linked Phosphoglycerokinase GeneGynecologic and Obstetric Investigation, 1995
- The epidemiology of hysterectomy: findings in a large cohort studyBJOG: An International Journal of Obstetrics and Gynaecology, 1992
- Risk factors for uterine fibroids: reduced risk associated with oral contraceptives.BMJ, 1986
- Diethylstilbestrol Usage: Its Interesting Past, Important Present, and Questionable FutureMedical Clinics of North America, 1974
- Adenocarcinoma of the vagina in adolescence.A report of 7 cases including 6 clear-cell carcinomas (so-called mesonephromas)Cancer, 1970